Literature DB >> 29741501

Targeted therapy for the adjuvant treatment of stage III BRAF-mutated melanoma.

Georgina Long1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29741501

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


× No keyword cloud information.
  1 in total

1.  Talimogene laherparepvec (T-VEC) in advanced melanoma: complete response in a heart and kidney transplant patient. A case report.

Authors:  J Ressler; R Silmbrod; A Stepan; F Tuchmann; A Cicha; K Uyanik-Ünal; C Hoeller
Journal:  Br J Dermatol       Date:  2019-03-26       Impact factor: 9.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.